Merck (MRK) EV to EBITDA (2009 - 2026)
Merck's EV to EBITDA came in at 23.67 for Q2 2026, up 196.4% from 7.99 a year earlier and up 47.9% from the prior quarter.
Powered by 
Analysis
Merck (MRK) EV to EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Merck reported EV to EBITDA of 20.73, up 223.8% year-over-year; for FY2025, it was 9.08, down 6.7% from FY2024.
- Going back by year, EV to EBITDA was 9.74 in FY2024 (+13.1%), 8.61 in FY2023 (-29.9%), 12.29 in FY2022 (+4.4%) and 11.77 in FY2021 (-47.3%).
- The Q2 2026 figure represents the highest quarterly EV to EBITDA since Q1 2024.
- Year-over-year, EV to EBITDA increased in two of the last eight quarters, with growth averaging 2.6%.
- The fastest year-over-year change in EV to EBITDA over five years came in Q2 2023 (growth of 199.4%), and the weakest in Q1 2025 (a decline of 67.5%).
- Business Quant data shows MRK's EV to EBITDA at 16.01 (Q1 2026), 9.08 (Q4 2025) and 7.25 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.67 |
| Mar 31, 2026 | 16.01 |
| Dec 31, 2025 | 9.08 |
| Sep 30, 2025 | 7.25 |
| Jun 30, 2025 | 7.99 |
| Mar 31, 2025 | 8.73 |
| Dec 31, 2024 | 9.74 |
| Sep 30, 2024 | 12.38 |
| Jun 30, 2024 | 12.77 |
| Mar 31, 2024 | 26.84 |
| Dec 31, 2023 | 25.99 |
| Sep 30, 2023 | 21.81 |
| Jun 30, 2023 | 29.32 |
| Mar 31, 2023 | 13.05 |
| Dec 31, 2022 | 12.29 |
| Sep 30, 2022 | 9.44 |
| Jun 30, 2022 | 9.79 |
| Mar 31, 2022 | 10.43 |
| Dec 31, 2021 | 11.77 |
| Sep 30, 2021 | 19.01 |
API Access
Merck EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();